Advocates compare Medicare expansion costs to defense spending as drug price bills stall

Prescription Drug Price Relief Act of 2025·Latest event August 21, 2026

7 hours ago

Advocates compare Medicare expansion costs to defense spending as drug price bills stall

Recent analysis suggests that expanding Medicare eligibility to age 50 would cost approximately $180 billion annually. This figure is lower than the $250 billion increase recently approved by the House for defense spending. Supporters argue these funds could prioritize domestic health needs over military expansion. The debate over healthcare costs continues as the Prescription Drug Price Relief Act of 2025 remains in committee. This legislation, introduced by Senator Sanders and Representative Khanna, targets high drug prices. It seeks to revoke patent exclusivity for drugs priced higher than the median in five other nations. By allowing generic competition, the bills aim to reduce the financial burden on the federal government and patients.

H.R. 3546Rep. Khanna Introduces Bill to End Drug Monopolies for Medicines Priced Higher Than in Other CountriesYale researchers found we could expand Medicare to 50 for $180 billion a year.S. 1818Sen. Sanders Introduces Bill to End Drug Monopolies for Medicines Priced Higher in U.S. Than Abroad

Policies

H.R. 3546 and S. 1818 are companion bills that introduce the same policy in the House and Senate. These identical versions allow the legislation to move through both chambers of Congress at the same time.

Rep. Khanna Introduces Bill to End Drug Monopolies for Medicines Priced Higher Than in Other Countries

H.R. 3546

Sen. Sanders Introduces Bill to End Drug Monopolies for Medicines Priced Higher in U.S. Than Abroad

S. 1818

Analysis generated by AI. Always verify with official sources.